MTRNR2L10

Across TCGA pan-cancer cohorts, MTRNR2L10 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated MTRNR2L10 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MTRNR2L10 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MTRNR2L10 expression acts as an unfavorable survival marker, although some lineages such as BLCA and ACC show a favorable association.

BLCA, ACC, and UCEC are the cancer types where MTRNR2L10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	II,III,IV	0.427	0.261	<.001	129	view →
ACC	DFS	Median	All	0.751	0.335	<.001	86	view →
UCEC	OS	Median	All	0.567	0.782	.006	62	view →
SCLC	OS	Tertile	All	1.000	0.656	.002	48	view →
LGG	OS	Median	All	0.947	0.846	<.001	27	view →
THYM	OS	Median	All	0.918	1.000	.009	23	view →
UCS	OS	Median	II,III,IV	0.421	0.749	.011	22	view →
ESCA	DFS	Median	II,III,IV	0.374	1.000	.006	18	view →
PAAD	OS	Tertile	II,III,IV	0.816	0.563	.018	15	view →
THCA	OS	Median	II,III,IV	1.000	0.655	.016	15	view →
MESO	DFS	Tertile	IV	0.722	0.298	.020	12	view →
READ	OS	Tertile	III,IV	0.790	0.268	.011	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

MTRNR2L10–BLCA (DFS)

Open the BLCA breakdown →